Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses PNTG in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named PNTG in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Brent Guerisoli | $444,711 | $0 | $662,117 | $885,588 | $1,737,874 | $0 | $9,186 | $3,739,476 |
| Chief Executive Officer | ||||||||
| John Gochnour | 369,711 | 0 | 613,016 | 811,789 | 1,586,966 | 0 | 10,190 | 3,391,672 |
| President and Chief Operating Officer | ||||||||
| Lynette Walbom | 338,654 | 0 | 471,922 | 664,191 | 1,178,055 | 0 | 7,606 | 2,660,428 |
| Chief Financial Officer | ||||||||
| Jason Steik | 283,654 | 1,031,274 | 0 | 516,593 | 0 | 0 | 1,765 | 1,833,286 |
| Chief Clinical Officer | ||||||||
| Kirk Cheney | 285,865 | 500,000 | 134,886 | 516,593 | 365,100 | 0 | 283 | 1,802,727 |
| EVP, General Counsel and Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Brent Guerisoli | $3,739,476 | — | — | — |
| John Gochnour | 3,391,672 | — | — | — |
| Lynette Walbom | 2,660,428 | — | — | — |
| Jason Steik | 1,833,286 | — | — | — |
| Kirk Cheney | 1,802,727 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Lynette Walbom | RSU | 2026-03-03 | — | 14,292 | 14,292 | 2 | $471,922 |
| John Gochnour | RSU | 2026-03-03 | — | 18,565 | 18,565 | 2 | 613,016 |
| Lynette Walbom | OPTION | 2025-05-16 | — | — | 45,000 | — | 664,191 |
| Kirk Cheney | RSU | 2026-03-03 | — | 4,085 | 4,085 | 2 | 134,886 |
| Brent Guerisoli | RSU | 2026-03-03 | — | 20,052 | 20,052 | 2 | 662,117 |
| Kirk Cheney | OPTION | 2025-05-16 | — | — | 35,000 | — | 516,593 |
| Brent Guerisoli | OPTION | 2025-05-16 | — | — | 60,000 | — | 885,588 |
| John Gochnour | OPTION | 2025-05-16 | — | — | 55,000 | — | 811,789 |
| Jason Steik | OPTION | 2025-05-16 | — | — | 35,000 | — | 516,593 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Lynette Walbom | $471,922 | $0 | $664,191 | 0.0% |
| John Gochnour | 613,016 | 0 | 811,789 | 0.0% |
| Kirk Cheney | 134,886 | 0 | 516,593 | 0.0% |
| Brent Guerisoli | 662,117 | 0 | 885,588 | 0.0% |
| Jason Steik | 0 | 0 | 516,593 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Brent Guerisoli | Option | 65,000 | 15.09 | — |
| John Gochnour | Option | 12,572 | 6.1 | — |
| John Gochnour | Option | 77,000 | 15.09 | — |
| John Gochnour | Option | 32,000 | 18.79 | — |
| Kirk Cheney | Option | 16,000 | 18.79 | — |
| John Gochnour | Option | 15,000 | 27.56 | — |
| John Gochnour | RSU | 16,000 | — | 450,400 |
| Brent Guerisoli | Option | 36,000 | 15.02 | — |
| Brent Guerisoli | Option | 40,000 | 38.88 | — |
| Brent Guerisoli | Option | 20,000 | 27.56 | — |
| Brent Guerisoli | Option | 14,282 | 6.16 | — |
| Brent Guerisoli | Option | 12,497 | 4.54 | — |
| Lynette Walbom | Option | 28,000 | 18.79 | — |
| Lynette Walbom | Option | 15,000 | 11.6 | — |
| John Gochnour | Option | 17,853 | 6.16 | — |
| Kirk Cheney | Option | 3,000 | 12.52 | — |
| Kirk Cheney | Option | 15,000 | 15.02 | — |
| Lynette Walbom | Option | 4,200 | 12.52 | — |
| Kirk Cheney | RSU | 5,600 | — | 157,640 |
| Brent Guerisoli | Option | 10,000 | 14.13 | — |
| Brent Guerisoli | Option | 40,000 | 18.79 | — |
| Brent Guerisoli | Option | 3,000 | 31.54 | — |
| Brent Guerisoli | Option | 8,926 | 3.84 | — |
| John Gochnour | Option | 4,200 | 12.52 | — |
| John Gochnour | Option | 4,000 | 14.13 | — |
| John Gochnour | Option | 8,926 | 4.54 | — |
| John Gochnour | Option | 15,000 | 38.88 | — |
| John Gochnour | Option | 6,000 | 37.98 | — |
| John Gochnour | Option | 3,000 | 31.54 | — |
| Brent Guerisoli | Option | 6,000 | 12.52 | — |
| Brent Guerisoli | RSU | 18,000 | — | 506,700 |
| Brent Guerisoli | Option | 6,000 | 37.98 | — |
| John Gochnour | Option | 8,926 | 3.84 | — |
| John Gochnour | Option | 27,000 | 15.02 | — |
We believe that compensation paid to our executive officers should be closely aligned with our performance and the performance of each individual executive officer on both a short-term and a long-term basis, based upon the value each executive officer provides to our Company, and designed to assist us in attracting and retaining the best possible executive talent, which we believe is critical to our long-term success.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | The Company engages periodically with a Compensation Adviser to review and advise the Compensation Committee on the Company's executive compensation. The Compensation Committee did not retain a Compensation Adviser relating to executive compensation in 2025, but did reference compensation studies performed for the Company previously. |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-14 | 21,632,263 | 5,954,153 | 26,138 | 78.42% | Passed |
| 2025 | 2025-05-16 | 18,745,276 | 6,947,663 | 22,181 | 72.96% | Passed |
| 2024 | 2024-05-23 | 13,703,355 | 7,599,880 | 12,365 | 64.33% | Passed |
| 2023 | 2023-05-25 | 20,042,765 | 888,881 | 20,659 | 95.75% | Passed |
| 2022 | 2022-06-01 | 24,855,389 | 261,625 | 5,995 | 98.96% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-14 | 78.42%a |
| 2025 | 2025-05-16 | 72.96%b |
| 2024 | 2024-05-23 | 64.33%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 98 : 1 |
|---|---|
| CEO total compensation | $3,739,476 |
| Median employee compensation | $38,063 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Scott E. LambIndependent · Lead Independent Director · Audit (Chair) · Nominating and Corporate Governance | $67,500 | $245,928 | $0 | $0 | $0 | $313,428 |
| John G. NackelIndependent · Compensation (Chair) · Audit | 64,500 | 194,693 | 0 | 0 | 0 | 259,193 |
| Barry M. SmithIndependent · Nominating and Corporate Governance (Chair) | 57,000 | 194,693 | 0 | 0 | 0 | 251,693 |
| Gregory K. MorrisIndependent · Quality Assurance and Compliance (Chair) | 54,000 | 194,693 | 0 | 0 | 0 | 248,693 |
| Stephen M. R. CoveyIndependent · Compensation · Nominating and Corporate Governance | 47,500 | 194,693 | 0 | 0 | 0 | 242,193 |
| Christopher R. ChristensenIndependent · Quality Assurance and Compliance | 42,000 | 194,693 | 0 | 0 | 0 | 236,693 |
| JoAnne StringfieldIndependent · Audit · Compensation · Departed during FY | 26,250 | 102,163 | 0 | 0 | 0 | 128,413 |
| Suzanne D. SnapperIndependent · Audit · Nominating and Corporate Governance · Newly elected | 30,938 | 92,530 | 0 | 0 | 0 | 123,468 |
| Brent J. GuerisoliEmployee director · Board Chair · Quality Assurance and Compliance | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $30,000 |
|---|---|
| Annual equity retainer | $194,693 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 22,500 / 15,000 |
| Stock ownership guideline | 33% of cumulative shares granted |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $389,688 |
| Equity awards (grant-date value) | $1,414,086 |
| All other compensation | $0 |
| Total cost of the board | $1,803,774 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Pennant Group names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Pennant Group.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Chemed Corporation | 2025 | Kevin McNamara | $1,862,837 | $2,883,553 | $5,036,021 | $1,486,976 | $12,904,720 |
| 2 | Brookdale Senior Living, Inc. | 2025 | Nikolas Stengle | 229,310 | 4,283,968 | 0 | 403,571 | 5,307,655 |
| 3 | Aveanna Healthcare Holdings Inc. | 2025 | Jeffrey Shaner | 750,000 | 2,603,993 | 0 | 1,500,000 | 4,864,165 |
| 4 | Pennant Group | 2025 | Brent Guerisoli | 444,711 | 662,117 | 885,588 | 1,737,874 | 3,739,476 |
| 5 | Sonida Senior Living Inc | 2025 | Brandon Ribar | 550,000 | 1,223,451 | 0 | 430,822 | 2,204,273 |
| — | Enhabit, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Addus Homecare Corporation | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Pennant Group | not disclosed | not disclosed | not disclosed | The Company engages periodically with a Compensation Adviser to review and advise the Compensation Committee on the Company's executive compensation. The Compensation Committee did not retain a Compensation Adviser relating to executive compensation in 2025, but did reference compensation studies performed for the Company previously. |
| Addus Homecare Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Aveanna Healthcare Holdings Inc. | 200% | PSU 50 · RSU 50 | No | Aon Human Capital Solutions (division of Aon plc) |
| Brookdale Senior Living, Inc. | 125.7% | PSU 60 · RSU 40 | No | F.W. Cook & Co., Inc. |
| Chemed Corporation | 60.4% | not disclosed | Yes — 3-Year Relative TSR | Compensation Strategies, Inc. |
| Enhabit, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Sonida Senior Living Inc | not disclosed | PSU 50 · RSU 50 | No | Meridian Compensation Partners, LLC |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Brent Guerisoli | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Summary Compensation Table” · page 27. As printed: 3,739,476. Filing ↗machine: r3 · c48 · span 361512–361521 |
| 2 | Section 01, John Gochnour | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Summary Compensation Table” · page 27. As printed: 3,391,672. Filing ↗machine: r9 · c48 · span 379197–379206 |
| 3 | Section 01, Lynette Walbom | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Summary Compensation Table” · page 27. As printed: 2,660,428. Filing ↗machine: r6 · c48 · span 370006–370015 |
| 4 | Section 01, Jason Steik | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Summary Compensation Table” · page 27. As printed: 1,833,286. Filing ↗machine: r15 · c48 · span 397176–397185 |
| 5 | Section 01, Kirk Cheney | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Summary Compensation Table” · page 27. As printed: 1,802,727. Filing ↗machine: r12 · c48 · span 388133–388142 |
| 6 | Section 03, Lynette Walbom RSU | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t39 · r6 · c4 · span 510083–510089 |
| 7 | Section 03, John Gochnour RSU | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t39 · r8 · c4 · span 514922–514928 |
| 8 | Section 03, Lynette Walbom OPTION | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t39 · r5 · c7 · span 508125–508131 |
| 9 | Section 03, Kirk Cheney RSU | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t39 · r10 · c4 · span 519759–519764 |
| 10 | Section 03, Brent Guerisoli RSU | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t39 · r4 · c4 · span 505243–505249 |
| 11 | Section 03, Kirk Cheney OPTION | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t39 · r9 · c7 · span 517801–517807 |
| 12 | Section 03, Brent Guerisoli OPTION | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t39 · r3 · c7 · span 503517–503523 |
| 13 | Section 03, John Gochnour OPTION | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t39 · r7 · c7 · span 512964–512970 |
| 14 | Section 03, Jason Steik OPTION | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “EXECUTIVE COMPENSATION COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t27 · r15 · c13 · span 395995–396002 |
| 15 | Section 07, pay ratio | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “CEO Pay Ratio”. As printed: 98 : 1. Filing ↗machine: span 757535–757539 |
| 16 | Section 08, Scott E. Lamb | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 313,428. Filing ↗machine: t17 · r7 · c8 · span 257639–257646 |
| 17 | Section 08, John G. Nackel | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 259,193. Filing ↗machine: t17 · r4 · c8 · span 251856–251863 |
| 18 | Section 08, Barry M. Smith | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 251,693. Filing ↗machine: t17 · r9 · c8 · span 261390–261397 |
| 19 | Section 08, Gregory K. Morris | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 248,693. Filing ↗machine: t17 · r8 · c8 · span 259519–259526 |
| 20 | Section 08, Stephen M. R. Covey | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 242,193. Filing ↗machine: t17 · r5 · c8 · span 253732–253739 |
| 21 | Section 08, Christopher R. Christensen | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 236,693. Filing ↗machine: t17 · r3 · c8 · span 250007–250014 |
| 22 | Section 08, JoAnne Stringfield | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 128,413. Filing ↗machine: t17 · r10 · c8 · span 263489–263496 |
| 23 | Section 08, Suzanne D. Snapper | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 123,468. Filing ↗machine: t17 · r6 · c8 · span 255606–255613 |
| 24 | Section 08, Brent J. Guerisoli | DEF 14A | 2026-03-31 | 0001766400-26-000027 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 25 | Section 06, 2026 vote | Form 8-K | 2026-05-20 | 0001766400-26-000056 | Item 5.07 · say-on-pay result. As reported: 78.42% (votes for as printed: 21,632,263). Filing ↗ |
| 26 | Section 06, 2025 vote | Form 8-K | 2025-05-20 | 0001766400-25-000071 | Item 5.07 · say-on-pay result. As reported: 72.96% (votes for as printed: 18,745,276). Filing ↗ |
| 27 | Section 06, 2024 vote | Form 8-K | 2024-05-29 | 0001766400-24-000063 | Item 5.07 · say-on-pay result. As reported: 64.33% (votes for as printed: 13,703,355). Filing ↗ |
| 28 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 29 | Section 09b board cost (computed) | Computed | — | computed | Cash 389,688 + equity 1,414,086 + all other 0 = 1,803,774, summed across the director compensation table rows.machine: formula: Σ = 1,803,774 |
| 30 | Chemed Corporation, Section 10b CEO total | DEF 14A | 2026-04-09 | 0001562762-26-000052 | CEO total compensation as printed in Chemed Corporation's own proxy. As printed: 12,904,720. Filing ↗machine: t18 · r8 · c8 · span 1091846–1091856 |
| 31 | Brookdale Senior Living, Inc., Section 10b CEO total | DEF 14A | 2026-04-30 | 0001193125-26-197412 | CEO total compensation as printed in Brookdale Senior Living, Inc.'s own proxy. As printed: 5,307,655. Filing ↗machine: t227 · r4 · c27 · span 1161767–1161776 |
| 32 | Aveanna Healthcare Holdings Inc., Section 10b CEO total | DEF 14A | 2026-04-17 | 0001193125-26-161632 | CEO total compensation as printed in Aveanna Healthcare Holdings Inc.'s own proxy. As printed: 4,864,165. Filing ↗machine: r3 · c31 · span 437702–437711 |
| 33 | Pennant Group (subject), Section 10b CEO total | DEF 14A | 2026-03-31 | 0001766400-26-000027 | CEO total compensation as printed in Pennant Group's own proxy. As printed: 3,739,476. Filing ↗machine: r3 · c48 · span 361512–361521 |
| 34 | Sonida Senior Living Inc, Section 10b CEO total | DEF 14A | 2026-04-27 | 0001193125-26-182027 | CEO total compensation as printed in Sonida Senior Living Inc's own proxy. As printed: 2,204,273. Filing ↗machine: span 215940–215949 |
| 35 | Section 10a, Chemed Corporation reciprocity | DEF 14A | — | 0001562762-26-000052 | Chemed Corporation's most recent proxy was read; its disclosed peer group does not include Pennant Group. Filing ↗ |
| 36 | Section 10a, Brookdale Senior Living, Inc. reciprocity | DEF 14A | — | 0001193125-26-197412 | Brookdale Senior Living, Inc.'s most recent proxy was read; its disclosed peer group does not include Pennant Group. Filing ↗ |
| 37 | Section 10a, Aveanna Healthcare Holdings Inc. reciprocity | DEF 14A | — | 0001193125-26-161632 | Aveanna Healthcare Holdings Inc. names Pennant Group in its own disclosed peer group (read from its most recent proxy). Filing ↗ |